Literature DB >> 9548754

ATP-Dependent human erythrocyte glutathione-conjugate transporter. I. Purification, photoaffinity labeling, and kinetic characteristics of ATPase activity.

S Awasthi1, S S Singhal, S K Srivastava, R T Torman, P Zimniak, J Bandorowicz-Pikula, S V Singh, J T Piper, Y C Awasthi, S Pikula.   

Abstract

Dinitrophenyl S-glutathione (DNP-SG) ATPase is a 38 kDa membrane protein expressed in erythrocytes and other tissues. Although stimulation of ATP hydrolysis catalyzed by DNP-SG ATPase has been demonstrated in the presence of several structurally unrelated amphiphilic ions, structural and functional properties of this protein have not been well-defined. In the present study, we have developed an improved protocol for the purification of DNP-SG ATPase and investigated its kinetic and substrate-binding properties. The purification procedure was based on highly specific elution of the 38 kDa protein from DNP-SG affinity resin in the presence of ATP. The protein could not be eluted using either ADP or adenosine-5'-[beta,gamma-methylene]triphosphate (methylene-ATP), a nonhydrolyzable analogue of ATP. Doxorubicin (DOX), a weakly basic anthracycline chemotherapy agent, was found to be the preferred activator for stimulation of ATP hydrolysis by the enzyme. ATP binding to the enzyme was demonstrated using 8-azido-ATP photoaffinity labeling and binding of trinitrophenyl (TNP)-ATP, a fluorescent analogue of ATP. The photoaffinity labeling of DNP-SG ATPase (38 kDa) was saturable with respect to 8-azido ATP (Kd = 2 microM), indicating that the enzyme was capable of specific and saturable binding to ATP. DNP-SG binding was evident from the purification procedure itself and was also demonstrable by quenching of tryptophan fluorescence. Results of quenching of tryptophan fluorescence as well as radioactive isotope-binding studies indicated that DOX was bound to the purified protein as well.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548754     DOI: 10.1021/bi972130z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

Review 1.  Role of RLIP76 in doxorubicin resistance in lung cancer.

Authors:  Rit Vatsyayan; Pankaj Chaudhary; Poorna Chandra Rao Lelsani; Preeti Singhal; Yogesh C Awasthi; Sanjay Awasthi; Sharad S Singhal
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

Review 2.  RLIP76: A novel glutathione-conjugate and multi-drug transporter.

Authors:  Sharad S Singhal; Sushma Yadav; Cherice Roth; Jyotsana Singhal
Journal:  Biochem Pharmacol       Date:  2008-10-15       Impact factor: 5.858

Review 3.  RLIP76 and Cancer.

Authors:  Sanjay Awasthi; Sharad S Singhal; Yogesh C Awasthi; Bryan Martin; Jung-Hee Woo; C Casey Cunningham; Arthur E Frankel
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

4.  Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugates.

Authors:  Sharad S Singhal; Archana Sehrawat; Amee Mehta; Mukesh Sahu; Sanjay Awasthi
Journal:  Int J Oncol       Date:  2009-01       Impact factor: 5.650

Review 5.  RLIP76: a versatile transporter and an emerging target for cancer therapy.

Authors:  Rit Vatsyayan; Poorna Chandra Rao Lelsani; Sanjay Awasthi; Sharad S Singhal
Journal:  Biochem Pharmacol       Date:  2010-01-25       Impact factor: 5.858

6.  Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76).

Authors:  Mikael C Herlevsen; Dan Theodorescu
Journal:  Biochem Biophys Res Commun       Date:  2007-08-08       Impact factor: 3.575

7.  RLIP76: a target for kidney cancer therapy.

Authors:  Sharad S Singhal; Jyotsana Singhal; Sushma Yadav; Mukesh Sahu; Yogesh C Awasthi; Sanjay Awasthi
Journal:  Cancer Res       Date:  2009-05-05       Impact factor: 12.701

8.  Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence.

Authors:  Song-Yuan Fan; Jian-Dong Jiang; Jun Qian; Yi-Cheng Lu; Guo-Han Hu; Chun Luo; Wei-Dong Hou; Qi Wang
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

9.  Rlip depletion prevents spontaneous neoplasia in TP53 null mice.

Authors:  Sanjay Awasthi; Joshua Tompkins; Jyotsana Singhal; Arthur D Riggs; Sushma Yadav; Xiwei Wu; Sharda Singh; Charles Warden; Zheng Liu; Jinhui Wang; Thomas P Slavin; Jeffrey N Weitzel; Yate-Ching Yuan; Meenakshi Awasthi; Satish K Srivastava; Yogesh C Awasthi; Sharad S Singhal
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-23       Impact factor: 11.205

10.  Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis.

Authors:  Sharda P Singh; Jihyun Lee; Chhanda Bose; Hongzhi Li; Yate-Ching Yuan; Ashly Hindle; Sharad S Singhal; Jonathan Kopel; Philip T Palade; Catherine Jones; Rakhshanda L Rahman; Sanjay Awasthi
Journal:  Cancers (Basel)       Date:  2021-07-02       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.